Optimal dosing of omeprazole 40 mg daily: Effects on gastric and esophageal pH and serum gastrin in healthy controls

American Journal of Gastroenterology

Volumn 91, Issue 8, 1996, Pages 1532-1538

  Kuo, Braden ^a   Castell, Donald O ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; OMEPRAZOLE;

ADULT; AMBULATORY MONITORING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ESOPHAGUS PH; GASTRIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH PH;

ADULT; ANTI-ULCER AGENTS; DRUG ADMINISTRATION SCHEDULE; ESOPHAGUS; GASTRIC ACID; GASTRINS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MONITORING, AMBULATORY; OMEPRAZOLE; SINGLE-BLIND METHOD;

EID: 0029738349     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lind T, Cederberg C, Ekenved G, et al. Effect of omeprazole, a gastric proton pump inhibitor, on pentagastrin-stimulated acid secretion in man. Gut 1983;24:270-6.
2. Physicians' desk reference, 46th ed. 1992:1531-3.
3. Fimmel C, Etienne A, Ciluffo T, et al. Long term ambulatory gastric pH monitoring: Validation of a new method and effect of H2 receptor antagonists. Gastroenterology 1985;88:1842-51.
4. Chiverton S, Howden C, Burget D, et al. Omeprazole (20 mg) daily given in the morning or evening: A comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration. Aliment Pharmacol Ther 1992;6:103-111.
5. Loyd-Davies K, Rutgersson K, Solvell L. Omeprazole in the treatment of Zollinger-Ellison syndrome: A 4-year international study. Aliment Pharmacol Ther 1988;2:13-32.
6. Klinkenberg-Knol E, Meuwissen S. Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990;4:485-95.
7. Klinkenberg-Knol EC, Festen HP, Jansen JB, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety. Ann Intern Med 1994;121:161-7.
8. Katzka D, Castell D. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994;89:989-91.
9. Walsh JH. Gastrointestinal hormones. In: Johnson LR, ed. Physiology of the gastrointestinal tract, ed 2. New York: Raven Press, 1987:181-253.
10. Cederberg C, Thomson A, Mahachai V, et al. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients. Gastroenterology 1992;103:913-8.
11. Prichard PJ, Neville YD, Mihaly GW, et al. Omeprazole: A study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 1985;88:64-9.
12. Sharma BK, Walt RP, et al. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984;25:957-64.
13. Emde C, Garner A, Blum A. Technical aspects of intraluminal pH-metry in man: Current status and recommendations. Gut 1987;28: 1177-88.
14. Fimme C, Etienne A, Cilluffo T, et al. Long term ambulatory gastric pH monitoring: Validation of a new method and effect of H2-antagonists. Gastroenterology 1985;88:1842-51.
15. Savarino V, Mela G, Scalabrini P, et al. 24 hour comparison between pH values of continuous intraluminal recording and simultaneous gastric aspiration. Scand J Gastroenterol 1987;22:135-40.
16. Angerer M, Koelzow H, Londong W. Simultaneous comparison of 24-hour intragastric pH recording using glass and antimony electrodes in man. Dig Dis 1990;8(suppl1):38-45.
17. DeVault K, DeNuna S, Georgeson S, et al. What is the best electrode for measuring gastric and esophageal pH? A direct comparison of glass and antimony electrodes. Gastroenterology 1993;104:A71 (abstract).
18. Johnson L, DeMeester T. Twenty-four hour pH monitoring of the distal esophagus. Am J Gastroenterol 1974;62:323.
19. Lam SK, Isenberg JI, Grossman MI, et al. Gastric acid secretion is abnormally sensitive to endogenous gastric released after peptone test meals in duodenal ulcer patients. J Clin Invest 1980;65:555-62.
20. 125I] radioimmunoassay kit, 9th rev. October, 1993.
21. Walsh JH, Debas HT, Grossman MI. Pure human big gastrin: Immunochemical properties, disappearance half time, and acid stimulating action in dogs. J Clin Invest 1974;54:477-85.
22. Johnson L. Regulation: Peptides of the gastrointestinal tract. In: Johnson L, ed. Gastrointestinal physiology, 3rd ed. St. Louis: C. V. Mosby, 1985:1-14.